News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
209,127 Results
Type
Article (18949)
Company Profile (120)
Press Release (190058)
Multimedia
Podcasts (33)
Webinars (9)
Section
Business (64790)
Career Advice (951)
Deals (11212)
Drug Delivery (37)
Drug Development (26003)
Employer Resources (72)
FDA (3088)
Job Trends (4666)
News (104614)
Policy (7149)
Tag
Academia (505)
Accelerated approval (1)
Adcomms (13)
Allergies (22)
Alliances (17900)
ALS (40)
Alzheimer's disease (465)
Antibody-drug conjugate (ADC) (95)
Approvals (3054)
Artificial intelligence (116)
Autoimmune disease (18)
Automation (5)
Bankruptcy (96)
Best Places to Work (3102)
BIOSECURE Act (19)
Biosimilars (31)
Biotechnology (111)
Bladder cancer (38)
Brain cancer (15)
Breast cancer (104)
Cancer (990)
Cardiovascular disease (70)
Career advice (770)
Career pathing (21)
CAR-T (110)
Cell therapy (303)
Cervical cancer (9)
Clinical research (21118)
Collaboration (477)
Company closure (1)
Compensation (144)
Complete response letters (11)
COVID-19 (771)
CRISPR (23)
C-suite (169)
Cystic fibrosis (43)
Data (898)
Denatured (5)
Depression (24)
Diabetes (75)
Diagnostics (1196)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (69)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (42)
Earnings (19117)
Editorial (19)
Employer branding (8)
Employer resources (69)
Events (34409)
Executive appointments (430)
FDA (3495)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (404)
Gene editing (61)
Generative AI (12)
Gene therapy (202)
GLP-1 (286)
Government (693)
Grass and pollen (1)
Guidances (46)
Healthcare (2718)
Huntington's disease (19)
IgA nephropathy (16)
Immunology and inflammation (83)
Indications (14)
Infectious disease (837)
Inflammatory bowel disease (75)
Inflation Reduction Act (3)
Influenza (24)
Intellectual property (49)
Interviews (140)
IPO (4698)
IRA (13)
Job creations (1680)
Job search strategy (707)
Kidney cancer (5)
Labor market (30)
Layoffs (194)
Leadership (14)
Legal (1681)
Liver cancer (22)
Lung cancer (108)
Lymphoma (77)
Machine learning (5)
Management (23)
Manufacturing (170)
MASH (26)
Medical device (1082)
Medtech (1083)
Mergers & acquisitions (6755)
Metabolic disorders (256)
Multiple sclerosis (39)
NASH (8)
Neurodegenerative disease (56)
Neuropsychiatric disorders (14)
Neuroscience (716)
NextGen: Class of 2025 (1513)
Non-profit (487)
Now hiring (21)
Obesity (139)
Opinion (177)
Ovarian cancer (38)
Pain (33)
Pancreatic cancer (35)
Parkinson's disease (57)
Partnered (11)
Patents (89)
Patient recruitment (42)
Peanut (13)
People (24165)
Pharmaceutical (15)
Phase I (7782)
Phase II (9805)
Phase III (6036)
Pipeline (593)
Policy (76)
Postmarket research (542)
Preclinical (3146)
Press Release (61)
Prostate cancer (35)
Psychedelics (18)
Radiopharmaceuticals (95)
Rare diseases (188)
Real estate (2539)
Recruiting (36)
Regulatory (5435)
Reports (23)
Research institute (547)
Resumes & cover letters (152)
Rett syndrome (1)
RNA editing (4)
RSV (17)
Schizophrenia (27)
Series A (90)
Series B (51)
Service/supplier (6)
Sickle cell disease (24)
Special edition (12)
Spinal muscular atrophy (49)
Sponsored (12)
Startups (1864)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (22)
The Weekly (28)
Vaccines (248)
Venture capitalists (38)
Weight loss (93)
Women's health (9)
Worklife (8)
Date
Last 7 days (374)
Last 30 days (1203)
Last 365 days (12679)
2025 (4733)
2024 (13368)
2023 (14083)
2022 (18649)
2021 (19347)
2020 (15319)
2019 (10839)
2018 (8546)
2017 (10373)
2016 (9453)
2015 (11181)
2014 (10977)
2013 (10247)
2012 (6918)
2011 (7221)
2010 (6618)
Location
Africa (338)
Alabama (32)
Alaska (3)
Arizona (51)
Arkansas (3)
Asia (14260)
Australia (2776)
California (2461)
Canada (767)
China (210)
Colorado (44)
Connecticut (95)
Delaware (51)
Europe (43521)
Florida (275)
Georgia (40)
Idaho (13)
Illinois (143)
India (14)
Indiana (120)
Iowa (4)
Japan (70)
Kansas (18)
Kentucky (4)
Louisiana (5)
Maine (2)
Maryland (358)
Massachusetts (1996)
Michigan (80)
Minnesota (128)
Missouri (18)
Montana (8)
Nebraska (5)
Nevada (13)
New Hampshire (7)
New Jersey (651)
New Mexico (11)
New York (617)
North Carolina (443)
North Dakota (5)
Northern California (1049)
Ohio (60)
Oklahoma (7)
Oregon (9)
Pennsylvania (529)
Puerto Rico (3)
Rhode Island (11)
South America (425)
South Carolina (2)
Southern California (973)
Tennessee (19)
Texas (291)
United States (8674)
Utah (31)
Virginia (34)
Washington D.C. (17)
Washington State (356)
Wisconsin (13)
209,127 Results for "trinity biotech plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Trinity Biotech plc to Announce Q1 2024 Financial Results
Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report financial results for the first quarter 2024 on Thursday, May 23, 2024 at 8:30 AM ET.
May 21, 2024
·
1 min read
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
Trinity Biotech plc will report financial results for the fourth quarter and fiscal year 2023 on Thursday, April 4, 2024 at 8:00 AM ET.
March 28, 2024
·
1 min read
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
Trinity Biotech Plc. announced that it has finalized the effective date of its ratio change of its American depositary shares from one ADS representing four Class A ordinary shares to one ADS representing twenty Class A ordinary shares.
February 15, 2024
·
3 min read
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Trinity Biotech Plc. announced that it plans to change the ratio of the American depositary shares representing its Class A ordinary shares from one ADS representing four Class A ordinary share to one ADS representing twenty Class A ordinary shares.
February 13, 2024
·
4 min read
Trinity Biotech plc to Host Investor Call - Jan 30, 2024
Trinity Biotech plc, a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations.
January 30, 2024
·
1 min read
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced steps to advance its next generation continuous glucose monitoring solution towards market launch.
June 24, 2024
·
4 min read
Press Releases
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process
March 13, 2025
·
5 min read
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
Trinity Biotech plc announced a strategic collaboration with medical artificial intelligence company PulseAI to enhance the Company’s recently acquired continuous glucose monitor biosensor technology.
May 16, 2024
·
5 min read
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology
Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced the launch of its continuous glucose monitoring microsite.
June 3, 2024
·
4 min read
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to attend the 84th Scientific Sessions of the American Diabetes Association in Orlando Florida, taking place on June 21-24, 2024.
June 10, 2024
·
1 min read
1 of 20,913
Next
